So, the Oncotype DX Breast Recurrence Score Test is both a prognostic test, since it provides more information about how likely or unlikely the breast cancer is to come back, and a predictive test, since it predicts the likelihood of benefit from chemotherapy or radiation therapy treatment <a href=http://doxycycline.world/>how long does it take doxycycline to work</a> 2008; 65 8 955 60 DOI PubMed
